Amarin (AMRN) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Underweight | $13.00 | Aug 21, 2026 |
| Goldman Sachs | Maintained | Sell | $12.00 from $7.00 | Jun 25, 2025 |
| Goldman Sachs | Maintained | Sell | $7.00 from $20.00 | Apr 17, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | — | Jun 20, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | — | Jun 18, 2024 |
| JP Morgan | Maintained | Underweight | — | Nov 20, 2023 |
| Jefferies | Downgraded | Buy → Hold | $1.00 from $3.00 | Oct 25, 2023 |
| Goldman Sachs | Maintained | Sell | $1.00 from $1.50 | Jul 20, 2023 |
| Northland Capital Markets | Maintained | Market Perform | $1.25 from $2.00 | Jul 19, 2023 |
Frequently asked questions
Is AMRN a buy, sell, or hold?
Analysts covering Amarin currently average a Sell rating: 0 buy, 0 hold and 1 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on AMRN?
On Aug 21, 2026, JP Morgan maintained Amarin at Underweight with a price target of $13.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.